Ascendia Pharmaceutical Solutions will exhibit at BIO 2026 International Convention, taking place June 22–25, 2026, at the San Diego Convention Center in San Diego, California. The event brings together global leaders across biotechnology, pharmaceutical development, and contract services.
Meet Ascendia Pharmaceutical Solutions at Booth 4451
Ascendia Pharmaceutical Solutions will host meetings at booth 4451, providing direct access to executive leadership and technical expertise. Attendees can engage in focused discussions on development strategy, formulation challenges, and manufacturing planning across the clinical and commercial lifecycle.
Click here to book your meeting with the team in advance of BIO 2026!
Executive Leadership Available for Strategic Discussions
Senior leadership from Ascendia Pharmaceutical Solutions will be present at booth #4451 and throughout the conference to support high-value conversations. Jim Huang, Ph.D. (Founder & CEO), Bob Bloder (CBO), Shaukat Ali, Ph.D. (Senior Director of Scientific Affairs), Jared Hahn (Senior Director of Business Development) and Julie Hilton (Senior Director of Business Development) will all be available to meet with both prospective partners and existing clients.
These sessions are structured to address specific program needs. Conversations will center on complex formulation approaches, scalable manufacturing solutions, and integrated development strategies that align with regulatory and commercial goals.
Policy engagement is also an important component of BIO. As a US-based CDMO, Ascendia looks forward to discussions around domestic manufacturing resilience and onshoring drug product formulation/manufacturing projects to the company’s New Jersey facility.
Focus on Complex Formulations and End-to-End Development
Ascendia Pharmaceutical Solutions specializes in enabling the development of challenging drug candidates. At BIO 2026, discussions will highlight capabilities in formulation development, bioavailability enhancement, and cGMP manufacturing.
The team will provide insight into how integrated services support efficient progression from early development through commercial supply. Emphasis will remain on solving technical barriers, improving product performance, and maintaining speed without compromising quality.
Direct Engagement Enables Faster Decision-Making
Meetings at booth 4451 are designed for efficiency. Sponsors will engage directly with decision-makers who can evaluate project requirements and outline practical next steps.
This format reduces delays associated with layered communication and enables alignment on scope, timelines, and technical direction during initial discussions.
Schedule a Meeting with Ascendia Pharmaceutical Solutions
BIO 2026 provides a critical opportunity to evaluate development and manufacturing partners. Ascendia Pharmaceutical Solutions offers the expertise, infrastructure, and leadership access required to advance complex pharmaceutical programs.
To discuss current and upcoming project needs, schedule a meeting with Ascendia Pharmaceutical Solutions’ team at booth 4451 via Ascendia’s calendar or the BIO One-on-One Partnering portal. Engage directly with executive leadership to define a clear path forward for development, scale-up, and commercialization.